DECR1 anticorps (AA 35-335)

N° du produit ABIN5776166

Cet anticorps anti-DECR1 est un anticorps Souris Monoclonal détectant DECR1 dans WB, ELISA, ICC, IF et FACS. Adapté pour Humain.

Aperçu rapide pour DECR1 anticorps (AA 35-335) (ABIN5776166)

Antigène: DECR1 (2,4-Dienoyl CoA Reductase 1, Mitochondrial (DECR1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp DECR1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone: AT3B2

Détail du produit anti-DECR1 anticorps

Épitope: AA 35-335

Immunogène: Recombinant human DECR1 (35-335aa) purified from E. coli

Isotype: IgG2b kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.

Détails sur DECR1

Antigène: DECR1 (2,4-Dienoyl CoA Reductase 1, Mitochondrial (DECR1))

Autre désignation: DECR1

Sujet: DECR1 is a mitochondrial protein that exists as a homotetramer and belongs to the family of short-chain dehydrogenases/reductases. It functions as an auxiliary enzyme of beta-oxidation andt participates in the metabolism of unsaturated fatty enoyl-CoA esters. Specifically, DECR1 uses NADP+ to catalyze the reduction of 2, 4-dienoyl-CoA to yield trans-3-enoyl-CoA, which can then be used as an intermediate in the Krebs cycle. Additionally, DECR1 is thought to function as a tumor suppressor, possibly downregulating the expression of Neu and slowing the rate of tumorigenesis.

NCBI Accession: NP_001350

Pathways: Monocarboxylic Acid Catabolic Process